Jiang Yue

Jiang Yue


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XWXiaoshuang Wang
Xiaoshuang Wang
JLJie Li
Jie Li
GDGuicheng Dong
Guicheng Dong
JYJiang Yue
Jiang Yue

10 April 2020 in Cell Cycle
Verified
Journal Article
Closed access
LLLing Li
Ling Li
KHKang Huang
Kang Huang
HZHuijia Zhao
Huijia Zhao
BCBinyao Chen
Binyao Chen
QYQifa Ye
Qifa Ye
JYJiang Yue
Jiang Yue
This study aims to investigate the potential mechanisms and identify core biomarkers of Hepatocellular carcinoma (HCC). The profile GSE113850 was downloaded to analyze the differentially expressed genes. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein–protein interaction network analysis were used to reveal the main signal pathways of the differentially expressed genes (DEGs) and hub genes. The correlation between core gene expression and pathological stages, the disease-free survival analysis, the overall survival analysis were analyzed by Gene Expression Profiling Interactive Analysis. Furthermore, we reidentified the expression level of core genes of carcinoma tissues and para-carcinoma tissues from 14 HCC patients with real-time reverse transcription-polymerase chain reaction analysis (RT-PCR) and western blotting. After SK-Hep1 cell was treated with cyclin-dependent kinase 1 (CDK1) siRNA for 72 h, we detected the expression of the core genes and fluorescence-activated cell sorting analysis. A total of 378 DEGs were found. GO and KEGG analysis revealed that the DEGs were mainly enriched in the cell cycle. There were positive correlations among CDK1, polo-like kinase 1, shugoshin2 and anillin actin-binding protein. Moreover, the expression levels of four core genes were related to the HCC occurrence, pathological stages, and survivorship curve. The clinical HCC specimens verified the higher expression level of core genes by real-time RT-PCR. The transfection of siCDK1 in SK-Hep1 resulted in a disordered cell cycle. Furthermore, CDK1 knockdown suppressed the expression of PLK1, ANLN, and SGOL2. The CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in the cell cycle might be a critical process in HCC.

26 August 2015 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
JLJie Li
Jie Li
MXMengmeng Xie
Mengmeng Xie
XWXiaoshuang Wang
Xiaoshuang Wang
XOXiufang Ouyang
Xiufang Ouyang
YWYu Wan
Yu Wan
JYJiang Yue
Jiang Yue

1 May 2004
Verified
Journal Article
Closed access
JYJiang Yue
Jiang Yue
RPRen-Xiu Peng
Ren-Xiu Peng
JYJing Yang
Jing Yang
RKRui Kong
Rui Kong
JLJuan Liu
Juan Liu

28 October 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
ZCZaishu Chen
Zaishu Chen
FZFurong Zhang
Furong Zhang
WHWeihua Hu
Weihua Hu
QCQijian Chen
Qijian Chen
CLChang Li
Chang Li
JYJiang Yue
Jiang Yue
Objectives: To investigate laboratory markers for COVID‐19 progression in patients with different medical conditions.Methods: We performed a multicenter retrospective study of 836 cases in Hubei. To avoid the collinearity among the indicators, principal component analysis (PCA) followed by partial least squares discriminant analysis (PLS‐DA) was performed to obtain an overview of laboratory assessments. Multivariable logistic regression analysis and multivariable Cox proportional hazards regression analysis were respectively used to explore risk factors associated with disease severity and mortality. Survival analysis was performed in patients with the most common comorbidities.Results: Lactate dehydrogenase (LDH) and prealbumin were associated with disease severity in patients with or without comorbidities, indicated by both PCA/PLS‐DA and multivariable logistic regression analysis. The mortality risk was associated with age, LDH, C‐reactive protein (CRP), D‐dimer, and lymphopenia in patients with comorbidities. CRP was a risk factor associated with short‐term mortality in patients with hypertension, but not liver diseases; additionally, D‐dimer was a risk factor for death in patients with liver diseases.Conclusions: Lactate dehydrogenase was a reliable predictor associated with COVID‐19 severity and mortality in patients with different medical conditions. Laboratory biomarkers for mortality risk were not identical in patients with comorbidities, suggesting multiple pathophysiological mechanisms following COVID‐19 infection.

1 January 2015 in Biochemical Pharmacology
Verified
Journal Article
Closed access
JLJie Li
Jie Li
YWYu Wan
Yu Wan
SNShufang Na
Shufang Na
XLXiaochan Liu
Xiaochan Liu
GDGuicheng Dong
Guicheng Dong
JYJiang Yue
Jiang Yue